Here are four drug and biotech stocks, ARQT, MESO, MNPR and KOD, which have more than doubled in 2024 with room for further growth in 2025.
US stocks fell Thursday as trading resumed after the Christmas holiday, as Wall Street digested one of the only significant economic data points of the week. Meanwhile, bitcoin (BTC-USD) slumped, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback